With the development of biological products and biotechnology drugs, as well as the need to increase the self medication for the treatment of patients with chronic diseases, drug makers have to rethink the traditional bottle injector model, in this context, a prefilled syringe gradually into people's eyes.

At present, most of the injectable drugs are supplied to the user through a sterile syringe and syringe, and the pre filled syringe is made of glass. Among the various types of pre filled syringes, 1.0ml syringes are the most popular. The choice of glass material because of its hard, chemically inert, stable and easy to disinfect. In addition, the transparency of the dose can be obvious. In recent years, the syringe manufacturer has introduced a plastic pre filled syringe to solve the problem of damage and piston failure. However, the glass syringe is still the "gold standard"".

Disposable prefilled syringe, more accurate dosage is rapidly replacing the traditional bottle syringe, and a prefilled syringe for protein drugs, drug release and other intravenous drug administration also has obvious advantages. In addition, pre filled syringes can help reduce dose errors, improve patient compliance, ensure sterility, reduce the possibility of contamination during injection. Its various advantages greatly promote its market expansion.

Pre filled syringes are not only beneficial to users, but also provide a number of benefits for pharmaceutical manufacturers. First of all, the cost of the unit of the injector is lower than that of the traditional syringe. This is because taking into account the injection preparation and drug delivery process may be easily lost, so the traditional mode of each tube is usually loaded with 10%~25% dose of drugs, and the accuracy of the pre filled syringes do not need to be so. At this point, the removal of multi drug loading, especially for the high cost of production of biopharmaceutical manufacturers, will greatly reduce costs.

From the various advantages of pre filled syringes mode can be predicted, it will be the main choice of bio pharmaceutical and other venous administration of the patient, but it is worth noting that the pharmaceutical companies see it in broad prospects for development at the same time, still should continue to develop innovation, exert its advantages and make up for its shortcomings, to promote a prefilled syringe better promotion mode.